Purchase Order 36C24523P0633
- Not listed
- This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) is for chemotherapy compounding services for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $97,052.49 and a performance period running through November 16, 2024. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy agents, hazardous sterile preparations,...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $1,283,466.63 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for patient-specific chemotherapy compounding services. Avella, a subsidiary of UnitedHealth Group Incorporated, will provide specialized pharmacy services to support VA oncology and infusion treatment programs nationwide. The award is not associated with a set-aside designation. Avella has...
- Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, has been awarded a $44,809.12 firm-fixed-price purchase order by the Department of Veterans Affairs' Veterans Health Administration Veterans Integrated Service Network 5 to provide custom dosed chemotherapy intravenous medications. As the prime contractor, Avella will compound customized chemotherapy and other hazardous sterile preparations based on patient-specific orders from the VA medical center in Phoenix, Arizona, to...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $976,800.00 firm-fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the emergency compounding of hazardous chemotherapy drugs. The order was awarded on November 27, 2018 with a performance period through January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, provides specialized pharmacy services to support VA oncology and infusion...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $699,995.00 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the provision of emergency compounded chemotherapy drugs. The period of performance was from February 1, 2019 to April 30, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, has received numerous VA-VHA awards to provide specialized pharmacy services involving chemotherapy and...
- The Department of Veterans Affairs (VA) has awarded a Delivery Order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $40,000.00 Firm Fixed Price contract is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Avella, which is a 503A certified pharmacy, will leverage its expertise in aseptic techniques for hazardous drug preparation to deliver customized...
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
- This federal contract award is for chemo compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2). The contract has a ceiling value of $283,000.00 and a period of performance through September 30, 2029. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy and other hazardous...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. This BPA call, valued at $500,000.00, is for the renewal of a contract to provide chemotherapy compounding services over a one-year period of performance ending on November 16, 2023. Avella will perform the work at its own facilities to support VA...
This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for the provision of custom dosed chemotherapy intravenous (IV) medications to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $132,504.84 firm fixed price purchase order has a period of performance through June 30, 2024. Avella Specialty Pharmacy is a subsidiary of UnitedHealth Group Incorporated and operates as a 503A certified pharmacy, specializing in compounding customized chemotherapy agents, hazardous sterile preparations, and other medications to support VA oncology and infusion treatment programs nationwide. This contract award is not designated as a set-aside. Avella Specialty Pharmacy has previously received multiple indefinite delivery contracts (IDCs) and blanket purchase agreements (BPAs) from the VA-VHA for nationwide chemotherapy compounding and hazardous pharmacy services, with contract values ranging from $2.5 million to $10 million.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Emergency Dosed Chemotherapy IV Medications | 36C24522Q0727 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 | Award Notice 1/1 | 3/27/24, 6:00 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($367k) | 8/9/24 | |
| Not listed | Not listed | $500.0k | 6/30/23 |